The Dermal Fillers Market in the Asia Pacific is anticipated to grow at a remarkable CAGR during the forecast period.
The growing influence majorly drives the growth of the dermal fillers market in the Asia Pacific amidst the women of middle age in enhancing their physical appearance and beauty awareness, which is likely to fuel market growth over the forecast period. Increasing discretionary income and rising familiarity of non-invasive about non-invasive cosmetic treatments that foster the dermal fillers' growth in this region. It is multiplying research and development activities by a massive number of key players in manufacturing the dermal fillers in the area.
Side effects associated with dermal fillers treatment such as itching, redness, and bruising, which harm the skin, are one major factor impeding the market. High costs associated with the dermal fillers and an increasing number of unlicensed practitioners, resulting in several faulty surgical methods are further expected to stand as an obstacle to market growth.
This research report has been segmented & sub-segmented into the following categories:
Based on geography, the developing nations in the Asia Pacific hold considerable potential for growth in the dermal filler market, due to its quick and accurate results without any risk on the skin.
Asia-Pacific for the dermal fillers market is estimated to grow with the highest CAGR rate during the analysis period due to the appearance of an enormous consumer base, essential advancements in medical infrastructure, and rapid economic development. Moreover, rising elder people population, augmenting demand for facial aesthetics products which boost the growth. Countries like China, India, and Japan are the major contributors to the APAC region.
China is expected to lead the market and is the most significant contributor in the dermal fillers' growth as there are tremendous opportunities with growing discretionary income, a rising number of dermatological consultations, skincare clinics, and increasing demand for skin specialists in the country. China is expected to grow with the highest CAGR of 8.7% over the analysis period. The key factor responsible for the growth of the market is the economy, which is becoming research and development, influence over average income integrated with changes made in consumer habits in the Chinese population.
Indian dermal filler market is estimated to grow with a CAGR of 8.9% over the review period as increasing awareness in developed and existing economies regarding the region's cosmetic procedures. The pharmaceutical companies in this country have been growing inevitably as a capability for the acquisition of advanced cosmetic procedures. Moreover, the growth is captured due to favorable demographics, socio-economic changes, and urbanization amidst motionless lifestyles.
Major companies operating in the APAC Dermal Fillers Market profiled in this report are Allergan Inc., AQTIS Medical, Bioha Laboratories, Suneva Medical, Galderma, Merz Aesthetics, Cynosure, Syneron, and Cytophil Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Absorbable or Biodegradable
5.1.3 Non-Absorbable or Non-Biodegradable
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Therapeutic Area
5.2.1 Introduction
5.2.2 Wrinkles
5.2.3 Deep Facial Lines
5.2.4 Sagging Skin
5.2.5 Scars
5.2.6 Y-o-Y Growth Analysis, By Therapeutic Area
5.2.7 Market Attractiveness Analysis, By Therapeutic Area
5.2.8 Market Share Analysis, By Therapeutic Area
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Therapeutic Area
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Therapeutic Area
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Therapeutic Area
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Allergan Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 AQTIS Medical
8.3 Bioha Laboratories
8.4 Suneva Medical
8.5 Galderma
8.6 Merz Aesthetics
8.7 Cynosure
8.8 Syneron
8.9 Cytophil Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
